dsu banner

Therapeutic Advances in Other Targetable Oncogenic Driver Mutations in NSCLC - Jin-Hyoung Kang

Document ID: SC-VN-01200

25/05/2021

Author: Boehringer Ingelheim

123,000
Views

100k 340

RELATED CONTENT

 
SC-VN-01200
Production date: May 2021